We are live on ! Find out more
LCC

Lincoln Capital Corp Portfolio holdings

AUM $308M
1-Year Est. Return 24.88%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+24.88%
3 Year Est. Return
+73.88%
5 Year Est. Return
+87.55%
10 Year Est. Return
AUM
$113M
AUM Growth
+$1.15M
Cap. Flow
-$1.5M
Cap. Flow %
-1.33%
Top 10 Hldgs %
44.63%
Holding
57
New
5
Increased
30
Reduced
8
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 26.54%
2 Technology 15.97%
3 Industrials 12.24%
4 Financials 9.73%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHP icon
1
Schwab US TIPS ETF
SCHP
$16.3B
$9M 7.96%
326,868
+2,568
+0.8% +$71.2K
MSFT icon
2
Microsoft
MSFT
$2.84T
$6.24M 5.52%
90,486
-18,336
-17% -$1.26M
GE icon
3
GE Aerospace
GE
$367B
$4.9M 4.34%
37,877
+113
+0.3% +$15.5K
SCHB icon
4
Schwab US Broad Market ETF
SCHB
$42.8B
$4.73M 4.18%
485,214
+22,122
+5% +$214K
JNJ icon
5
Johnson & Johnson
JNJ
$634B
$4.45M 3.94%
33,668
+306
+0.9% +$39K
NXPI icon
6
NXP Semiconductors
NXPI
$68B
$4.45M 3.94%
40,681
+10,434
+34% +$1.12M
KSU
7
DELISTED
Kansas City Southern
KSU
$4.3M 3.8%
41,077
+651
+2% +$61K
ORCL icon
8
Oracle
ORCL
$331B
$4.21M 3.72%
83,912
+1,158
+1% +$52.8K
TXT icon
9
Textron
TXT
$16.6B
$4.1M 3.62%
+87,023
New +$4.09M
MRK icon
10
Merck
MRK
$324B
$4.08M 3.61%
66,806
+453
+0.7% +$27.6K
CELG
11
DELISTED
Celgene Corp
CELG
$3.97M 3.51%
30,580
+185
+0.6% +$22.7K
ABT icon
12
Abbott
ABT
$180B
$3.9M 3.44%
80,136
+291
+0.4% +$13.2K
BNY
13
Bank of New York Mellon
BNY
$108B
$3.85M 3.4%
75,366
+35
+0% +$1.67K
MET icon
14
MetLife
MET
$61B
$3.81M 3.37%
77,734
+11,429
+17% +$530K
ABBV icon
15
AbbVie
ABBV
$458B
$3.65M 3.23%
50,327
+475
+1% +$31.9K
COR icon
16
Cencora
COR
$60.3B
$3.48M 3.08%
36,841
+7,120
+24% +$634K
JPM icon
17
JPMorgan Chase
JPM
$939B
$3.15M 2.78%
34,455
+985
+3% +$85K
AMGN icon
18
Amgen
AMGN
$203B
$3.07M 2.71%
17,816
-25
-0.1% -$4.07K
ABCO
19
DELISTED
Advisory Board Co
ABCO
$3.03M 2.68%
58,806
+461
+0.8% +$23.1K
COP icon
20
ConocoPhillips
COP
$147B
$2.24M 1.98%
50,968
+1,678
+3% +$78.3K
APA icon
21
APA Corp
APA
$12.8B
$2.23M 1.97%
46,538
+5,805
+14% +$286K
NOBL icon
22
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
$2.19M 1.94%
75,986
+2,510
+3% +$71.8K
FLRN icon
23
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$2.16M 1.91%
70,171
+39,740
+131% +$1.22M
SLB icon
24
SLB Ltd
SLB
$78.4B
$1.94M 1.71%
29,423
-406
-1% -$29.1K
CVS icon
25
CVS Health
CVS
$137B
$1.93M 1.71%
24,004
-7,488
-24% -$591K

Similar funds

Lincoln Capital Corp's Q2 2017 Portfolio in Review

As of Q2 2017, Lincoln Capital Corp held 57 positions worth $113M, up 1% from $112M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Lincoln Capital Corp's Q2 2017 filing shows 5 new, 30 increased, 8 reduced and 8 closed positions. Its largest new stake was Textron: 87,023 shares worth $4.1M. The largest sale was Procter & Gamble, an estimated $3.08M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Lincoln Capital Corp's largest Q2 2017 buy was Textron: 87,023 shares worth $4.1M.
  • Lincoln Capital Corp added most to State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q2 2017, an estimated $1.22M increase.
  • Lincoln Capital Corp's biggest Q2 2017 reduction was Cisco, cutting an estimated $2.59M.
  • Lincoln Capital Corp fully exited Procter & Gamble in Q2 2017, selling an estimated $3.08M.
  • Lincoln Capital Corp's ten largest holdings make up 45% of its $113M portfolio in Q2 2017.
  • Lincoln Capital Corp opened 5 new positions and closed 8 in Q2 2017.
  • Lincoln Capital Corp's portfolio value rose 1% quarter-over-quarter to $113M.

Based on Lincoln Capital Corp's 13F filing for Q2 2017, filed 25 Jul 2017.